Evaluation of the effects of Losartan in patients with corona virus disease 2019

INTERVENTION: Intervention 1: Intervention group: In the case group, patients will receive 25 mg losartan tablets two times daily. Intervention 2: Intervention group: Patients will receive 5 mg amlodipine daily. CONDITION: B34.2 Corona virus disease 2019 (COVID‐19). ; Coronavirus infection, unspecified PRIMARY OUTCOME: Laboratory Findings. Timepoint: Primary and 14 days after. Method of measurement: Laboratory methods. Length of hospitalization. Timepoint: 28 days. Method of measurement: Days between admission to discharge. Mortality. Timepoint: 28 days. Method of measurement: Number of death. Performance of patients. Timepoint: Primary and 14 days after. Method of measurement: Sequential Organ Failure Assessment (SOFA) Respiratory Score. INCLUSION CRITERIA: Laboratory (RT‐PCR of oropharyngeal swab) confirmed COVID‐19 Stable hemodynamic condition Blood pressure =130/85 mmHg